Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucobrassicin is a naturally occurring indole glucosinolate found in cruciferous vegetables, such as broccoli, Brussels sprouts, and cabbage, as well as in the traditional Chinese medicine herb Northern Ban Lan (*Isatis tinctoria*). It serves as the precursor to bioactive indoles, primarily indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM), which are released upon enzymatic hydrolysis by myrosinase or gut microbiota. Glucobrassicin itself has been shown to possess anti-microtubule activity, disrupting microtubule networks and inducing apoptosis in cancer cells. Its downstream metabolites, I3C and DIM, exhibit chemopreventive, anti-inflammatory, and anticancer properties by modulating the aryl hydrocarbon receptor (AhR), estrogen receptor signaling, and cellular detoxification pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucobrassicin.